GO
Loading...

U.S. Regulators OK Generic Version Of Ambien Sleeping Pill

Mylan Laboratories said U.S. regulators approved its generic version of Sanofi-Aventis' sleeping pill, Ambien, in the 5 mg and 10 mg strengths.

In a statement, the generic drug maker said the product is being shipped immediately.

Ambien had sales of about $2.2 billion in the U.S. for the same strengths for the 12-month period ending Dec. 31, 2006, according to IMS Health.

Sanofi-Aventis lost patent protection for Ambien on April 21. Ambien dominates the U.S. sleeping pill market, which is growing at about 10% a year.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More

Don't Miss

U.S. Video